These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 2417931
1. The value of immunohistochemistry in medullary thyroid carcinoma: a systematic study of 30 cases. Krisch K, Krisch I, Horvat G, Neuhold N, Ulrich W. Histopathology; 1985 Oct; 9(10):1077-89. PubMed ID: 2417931 [Abstract] [Full Text] [Related]
2. Epithelial markers in thyroid carcinoma: an immunoperoxidase study. Wilson NW, Pambakian H, Richardson TC, Stokoe MR, Makin CA, Heyderman E. Histopathology; 1986 Aug; 10(8):815-29. PubMed ID: 2428725 [Abstract] [Full Text] [Related]
3. Medullary carcinoma of the thyroid. An immunocytochemical and histochemical study of 25 cases using eight separate markers. Sikri KL, Varndell IM, Hamid QA, Wilson BS, Kameya T, Ponder BA, Lloyd RV, Bloom SR, Polak JM. Cancer; 1985 Nov 15; 56(10):2481-91. PubMed ID: 2412687 [Abstract] [Full Text] [Related]
4. Calcitonin, carcinoembryonic antigen and neuron-specific enolase in medullary thyroid carcinoma. Lloyd RV, Sisson JC, Marangos PJ. Cancer; 1983 Jun 15; 51(12):2234-9. PubMed ID: 6342746 [Abstract] [Full Text] [Related]
5. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique. Talerman A, Lindeman J, Kievit-Tyson PA, Dröge-Droppert C. Histopathology; 1979 Nov 15; 3(6):503-10. PubMed ID: 389771 [Abstract] [Full Text] [Related]
6. An immunohistochemical study in thyroid cancer. Beltrami CA, Barbatelli G, Criante P, Paliaga A, Amadi CE. Appl Pathol; 1987 Nov 15; 5(4):229-45. PubMed ID: 2446641 [Abstract] [Full Text] [Related]
7. Medullary carcinoma of the thyroid gland. Clinical, pathological, and immunohistochemical features with review of the literature. Uribe M, Fenoglio-Preiser CM, Grimes M, Feind C. Am J Surg Pathol; 1985 Aug 15; 9(8):577-94. PubMed ID: 2418697 [Abstract] [Full Text] [Related]
8. Neuroendocrine carcinoma of the skin: an immunohistochemical study of tumor markers and neuroendocrine products. Layfield L, Ulich T, Liao S, Barr R, Cheng L, Lewin KL. J Cutan Pathol; 1986 Aug 15; 13(4):268-73. PubMed ID: 2430002 [Abstract] [Full Text] [Related]
9. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma. Bethge N, Ahuja S, Diel F. Exp Clin Endocrinol; 1986 Dec 15; 88(3):365-72. PubMed ID: 2881797 [Abstract] [Full Text] [Related]
10. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen. Purnell DM, Heatfield BM, Trump BF. Cancer Res; 1984 Jan 15; 44(1):285-92. PubMed ID: 6197163 [Abstract] [Full Text] [Related]
11. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen. Burg-Kurland CL, Purnell DM, Combs JW, Hillman EA, Harris CC, Trump BF. Cancer Res; 1986 Jun 15; 46(6):2936-43. PubMed ID: 2421889 [Abstract] [Full Text] [Related]
12. Neuroendocrine differentiation in non-neuroendocrine thyroid carcinoma. Kargi A, Yörükoglu, Aktaş S, Cakalagaoglu, Ermete M. Thyroid; 1996 Jun 15; 6(3):207-10. PubMed ID: 8837328 [Abstract] [Full Text] [Related]
13. Medullary carcinoma of the thyroid gland: an immunocytochemical study. Holm R, Sobrinho-Simões M, Nesland JM, Gould VE, Johannessen JV. Ultrastruct Pathol; 1985 Jun 15; 8(1):25-41. PubMed ID: 3901454 [Abstract] [Full Text] [Related]
14. Medullary differentiation of anaplastic thyroid carcinoma. Nieuwenhuijzen Kruseman AC, Bosman FT, van Bergen Henegouw JC, Cramer-Knijnenburg G, Brutel de la Riviere G. Am J Clin Pathol; 1982 May 15; 77(5):541-7. PubMed ID: 6177234 [Abstract] [Full Text] [Related]
15. Thyroid medullary carcinoma with thyroglobulin immunoreactivity in sporadic multiple endocrine neoplasia type 2-B. Kovacs CS, Masé RM, Kovacs K, Nguyen GK, Chik CL. Cancer; 1994 Aug 01; 74(3):928-32. PubMed ID: 7913660 [Abstract] [Full Text] [Related]
16. Oxyphil and squamous variants of medullary thyroid carcinoma. Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M, Gould E, Albores-Saavedra J. Cancer; 1989 Mar 15; 63(6):1183-8. PubMed ID: 2917321 [Abstract] [Full Text] [Related]
17. A study of FoxA1 expression in thyroid tumors. Nonaka D. Hum Pathol; 2017 Jul 15; 65():217-224. PubMed ID: 28546130 [Abstract] [Full Text] [Related]
18. Regulatory peptides and other neuroendocrine markers in medullary carcinoma of the thyroid. Hanna FW, Ardill JE, Johnston CF, Cunningham RT, Curry WJ, Russell CF, Buchanan KD. J Endocrinol; 1997 Feb 15; 152(2):275-81. PubMed ID: 9071985 [Abstract] [Full Text] [Related]
19. Multiple endocrine cell types in thyroid medullary carcinoma. Evidence for calcitonin, somatostatin, ACTH, 5HT and small granule cells. Capella C, Bordi C, Monga G, Buffa R, Fontana P, Bonfanti S, Bussolati G, Solcia E. Virchows Arch A Pathol Anat Histol; 1978 Feb 10; 377(2):111-28. PubMed ID: 205037 [Abstract] [Full Text] [Related]
20. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases]. Charpin C, Argemi B, Cannoni M, Oliver C, Gillioz P, Vagneur JP, Toga M. Ann Pathol; 1984 Feb 10; 4(1):27-35. PubMed ID: 6142718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]